Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ECALLANTIDE for Immunodeficiency common variable: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where ECALLANTIDE was used for Immunodeficiency common variable.

Most Reported Side Effects for ECALLANTIDE

Side Effect Reports % Deaths Hosp.
Hereditary angioedema 519 43.0% 8 335
Off label use 139 11.5% 1 56
Drug ineffective 89 7.4% 1 53
Malaise 60 5.0% 1 28
Product dose omission issue 57 4.7% 1 38
Headache 54 4.5% 1 21
Weight decreased 52 4.3% 0 38
Pain 50 4.2% 1 19
Weight increased 47 3.9% 0 32
Hypersensitivity 38 3.2% 0 14
Inappropriate schedule of product administration 38 3.2% 2 21
Nausea 38 3.2% 0 15
Therapeutic response decreased 38 3.2% 0 21
Urticaria 38 3.2% 0 8
Covid-19 36 3.0% 1 26

Other Indications for ECALLANTIDE

Hereditary angioedema (980) Immune system disorder (132) Product used for unknown indication (102) Angioedema (13) Hereditary angioedema with normal c1 esterase inhibitor (6) Idiopathic angioedema (6) Asthma (5)

Other Drugs Used for Immunodeficiency common variable

HUMAN IMMUNOGLOBULIN G (17,389) HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (1,598) HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (881) GAMMAGARD LIQUID (81) HIZENTRA (76) DUPILUMAB (69) RITUXIMAB (44) INFLIXIMAB (28) PREDNISOLONE (27) HUMAN C1-ESTERASE INHIBITOR (24)

Related Pages

ECALLANTIDE Full Profile All Immunodeficiency common variable Drugs ECALLANTIDE Demographics ECALLANTIDE Timeline